Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.
Cancer Cell Int
; 22(1): 422, 2022 Dec 30.
Article
in En
| MEDLINE
| ID: mdl-36585738
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Cancer Cell Int
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: